Skip to content

FENNEC PHARMACEUTICALS INC.

FENC

CIK 0001211583

← back to feed
Revenue (TTM)
$45.97M
−6.1% YoY Q1 May 2026
Net Income (TTM)
−$4.75M
−2,134.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.16
−1,600.0% YoY Q1 May 2026
Gross Margin
43.5%
Q1 May 2026
Operating Margin
-8.4%
Q1 May 2026
Net Margin
-10.3%
Q1 May 2026
Free Cash Flow (TTM)
$31.53M
Q1 May 2026
Cash
$40.18M
Q1 May 2026
Total Debt
$26M
Q1 May 2026
Shares Outstanding
34.74M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings